Symptomatic melanoma metastases in the brain: are we using all therapy options?
In recent years, significant advances have been made in systemic therapy for patients with metastatic melanoma of the skin, resulting in an increase in one-year overall survival (OS) from 25 to 85% and 5-year OS from less than 10 to 60% in certain patient subgroups. Approximately 50% of patients wit...
| Main Authors: | , , , |
|---|---|
| 格式: | Article |
| 語言: | Russian |
| 出版: |
Remedium Group LLC
2022-06-01
|
| 叢編: | Медицинский совет |
| 主題: | |
| 在線閱讀: | https://www.med-sovet.pro/jour/article/view/6918 |